A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:November 2, 2007Completed
Hide Studies Not Open or Pending
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:November 2, 2007Completed
Condition(s):Cognitive Change; Memory; Disturbance, Mild; Emotional Regulation; Concentration Ability ImpairedLast Updated:April 11, 2023Completed
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:November 6, 2007Completed
Condition(s):VertigoLast Updated:May 17, 2023Completed
Condition(s):Healthy SubjectsLast Updated:April 13, 2018Terminated
Condition(s):Frontotemporal DementiaLast Updated:February 23, 2024Recruiting
Condition(s):Brain MicrometastasesLast Updated:March 20, 2015Unknown status
Condition(s):Brain MetastasesLast Updated:June 23, 2016Completed
Condition(s):Tuberculosis; HIVLast Updated:January 18, 2022Completed
Condition(s):Brain MetastasesLast Updated:November 28, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.